Can Shear Wave Elastography Predict the Success of ESWL: a Prospective Study

Sponsor
Abdelrahim Elsherbiny (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05995652
Collaborator
(none)
50
1
4.1
12.3

Study Details

Study Description

Brief Summary

Can Shear Wave Elastography predict the success of Shock-Wave Lithotripsy used in renal stones treatment ? A prospective study

Condition or Disease Intervention/Treatment Phase
  • Procedure: elastography

Detailed Description

Extracorporeal shock-wave lithotripsy (ESWL) is the noninvasive treatment method that is recommended as the first choice in the treatment of small and medium sized renal stones and proximal ureteral stones.

This study is a trial to determine the predictive role of shear wave elastography in the success of ESWL management of kidney stones.

Study Design

Study Type:
Observational
Anticipated Enrollment :
50 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Can Shear Wave Elastography Predict the Success of Shock-Wave Lithotripsy Used in Renal Stones Treatment: a Prospective Study
Anticipated Study Start Date :
Aug 30, 2023
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jan 1, 2024

Arms and Interventions

Arm Intervention/Treatment
ESWL sucess and failed gps

post ESWL 50 pt large gp will be devided into sucess gp and failed gp

Procedure: elastography
elastography

Outcome Measures

Primary Outcome Measures

  1. stone free rate [1 month]

    post ESWL

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patients more than 18 years

  • With single radiopaque renal stone

  • Ranging in size from (1-1,5 cm) for ESWL.

Exclusion Criteria:
  • Any urological abnormal anatomy

  • Lower calyceal stone more than 1cm

  • Impaired renal functions

  • Uncorrected coagulopathy.

  • Active UTI Pregnancy Single kidney Multiple stones

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine Ain Shams University Cairo Egypt

Sponsors and Collaborators

  • Abdelrahim Elsherbiny

Investigators

  • Study Chair: tarek elzayat, prof.dr., AinShams

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Abdelrahim Elsherbiny, assistant lecturer at urology department, Ain shams university, Ain Shams University
ClinicalTrials.gov Identifier:
NCT05995652
Other Study ID Numbers:
  • Abdelrahim Elsherbiny
First Posted:
Aug 16, 2023
Last Update Posted:
Aug 22, 2023
Last Verified:
Aug 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 22, 2023